14-104771343-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001382430.1(AKT1):​c.1261-496C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.396 in 241,766 control chromosomes in the GnomAD database, including 19,989 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 13041 hom., cov: 32)
Exomes 𝑓: 0.38 ( 6948 hom. )

Consequence

AKT1
NM_001382430.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.75

Publications

27 publications found
Variant links:
Genes affected
AKT1 (HGNC:391): (AKT serine/threonine kinase 1) This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
AKT1 Gene-Disease associations (from GenCC):
  • Proteus syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 6
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.612 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKT1NM_001382430.1 linkc.1261-496C>G intron_variant Intron 13 of 14 ENST00000649815.2 NP_001369359.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKT1ENST00000649815.2 linkc.1261-496C>G intron_variant Intron 13 of 14 NM_001382430.1 ENSP00000497822.1 P31749-1

Frequencies

GnomAD3 genomes
AF:
0.406
AC:
61665
AN:
151792
Hom.:
13033
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.465
Gnomad AMI
AF:
0.299
Gnomad AMR
AF:
0.471
Gnomad ASJ
AF:
0.299
Gnomad EAS
AF:
0.631
Gnomad SAS
AF:
0.548
Gnomad FIN
AF:
0.371
Gnomad MID
AF:
0.408
Gnomad NFE
AF:
0.342
Gnomad OTH
AF:
0.394
GnomAD4 exome
AF:
0.380
AC:
34114
AN:
89856
Hom.:
6948
Cov.:
0
AF XY:
0.379
AC XY:
15968
AN XY:
42154
show subpopulations
African (AFR)
AF:
0.459
AC:
1803
AN:
3928
American (AMR)
AF:
0.462
AC:
1756
AN:
3798
Ashkenazi Jewish (ASJ)
AF:
0.300
AC:
1539
AN:
5122
East Asian (EAS)
AF:
0.572
AC:
6555
AN:
11454
South Asian (SAS)
AF:
0.463
AC:
948
AN:
2048
European-Finnish (FIN)
AF:
0.314
AC:
118
AN:
376
Middle Eastern (MID)
AF:
0.348
AC:
181
AN:
520
European-Non Finnish (NFE)
AF:
0.335
AC:
18565
AN:
55444
Other (OTH)
AF:
0.370
AC:
2649
AN:
7166
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1017
2034
3051
4068
5085
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.406
AC:
61721
AN:
151910
Hom.:
13041
Cov.:
32
AF XY:
0.411
AC XY:
30512
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.465
AC:
19251
AN:
41390
American (AMR)
AF:
0.471
AC:
7199
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.299
AC:
1036
AN:
3464
East Asian (EAS)
AF:
0.630
AC:
3238
AN:
5140
South Asian (SAS)
AF:
0.547
AC:
2635
AN:
4818
European-Finnish (FIN)
AF:
0.371
AC:
3927
AN:
10574
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.342
AC:
23212
AN:
67930
Other (OTH)
AF:
0.396
AC:
834
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1815
3630
5445
7260
9075
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
588
1176
1764
2352
2940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.378
Hom.:
1439
Bravo
AF:
0.414
Asia WGS
AF:
0.587
AC:
2041
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.29
DANN
Benign
0.63
PhyloP100
-3.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2494731; hg19: chr14-105237680; API